Detalles de la búsqueda
1.
Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial.
Ann Rheum Dis
; 79(1): 94-102, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31630117
2.
Three-year safety and two-year effectiveness of etanercept in patients with rheumatoid arthritis in Japan: Results of long-term postmarketing surveillance.
Mod Rheumatol
; 29(5): 737-746, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30092161
3.
Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance.
Mod Rheumatol
; 29(5): 747-755, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30217117
4.
Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance study.
Mod Rheumatol
; 29(2): 314-323, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29611761
5.
Defective renal autoregulation in the chronic bile duct ligation model of liver failure.
Clin Exp Nephrol
; 22(5): 1052-1060, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29516300
6.
Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-modifying antirheumatic drugs: Final results of the GO-MONO trial through week 120.
Mod Rheumatol
; 28(5): 770-779, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29219638
7.
Clinical benefit of 1-year certolizumab pegol (CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritis was observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial.
Ann Rheum Dis
; 76(8): 1348-1356, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28153828
8.
Semi-Automated Quantification of Finger Joint Space Narrowing Using Tomosynthesis in Patients with Rheumatoid Arthritis.
J Digit Imaging
; 30(3): 369-375, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28105533
9.
Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in Japan.
Mod Rheumatol
; 27(5): 755-765, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27919207
10.
Maintenance treatment using abatacept with dose reduction after achievement of low disease activity in patients with rheumatoid arthritis (MATADOR) - A prospective, multicenter, single arm pilot clinical trial.
Mod Rheumatol
; 27(6): 930-937, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28150514
11.
The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
Ann Rheum Dis
; 75(1): 75-83, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26139005
12.
Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy.
Mod Rheumatol
; 26(1): 80-6, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26054418
13.
Prevention of joint destruction in patients with high disease activity or high C-reactive protein levels: Post hoc analysis of the GO-FORTH study.
Mod Rheumatol
; 26(3): 323-30, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26471830
14.
Post-hoc analysis showing better clinical response with the loading dose of certolizumab pegol in Japanese patients with active rheumatoid arthritis.
Mod Rheumatol
; 26(4): 473-80, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26472043
15.
Clinical efficacy, radiographic progression, and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis despite prior methotrexate therapy: final results of the randomized GO-FORTH trial.
Mod Rheumatol
; 26(4): 481-90, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26474192
16.
Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan.
Mod Rheumatol
; 26(5): 642-50, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26873430
17.
Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis.
Mod Rheumatol
; 26(4): 491-8, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26635183
18.
Safety, pharmacokinetics, and pharmacodynamics of epratuzumab in Japanese patients with moderate-to-severe systemic lupus erythematosus: Results from a phase 1/2 randomized study.
Mod Rheumatol
; 26(1): 87-93, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26382733
19.
Consensus-based identification of factors related to false-positives in ultrasound scanning of synovitis and tenosynovitis.
Mod Rheumatol
; 26(1): 9-14, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26382930
20.
A genome-wide association study identified AFF1 as a susceptibility locus for systemic lupus eyrthematosus in Japanese.
PLoS Genet
; 8(1): e1002455, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22291604